Skip to main content
PolicySpeak
← All files
APE

APETP

NGO · Spain · EU Transparency Register 745769829051-55

2
positions filed
in the 583 files tracked
1
legislative file
of 583 tracked
1
with a full position paper
attached to a submission

Counts here are a floor, never a total: they cover the 583 consultation files tracked so far (42,224 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.

Who they are

Among the 964 non-governmental organisations on this site, they rank #578 by legislative files engaged — a count of participation, not a measure of influence.

2.5
declared lobbying FTE
self-declared
declared costs / yr (floor)
0
EP accreditations
as declared to the register
2017
in the register since

Declares membership of

  • APETP no es miembro
  • asociado
  • patrocinador o contribuyente de otras entidades.

Self-declared to the EU Transparency Register (snapshot 2 Sept 2026).

Register category
Non-governmental organisations
Registered as
Asociación para Proteger al Enfermo de Terapias Pseudocientíficas (APETP)
Head office
Algemesí, Spain

Self-declared to the EU Transparency Register (snapshot 2 Sept 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.

Track APETP in PolicySpeak: request access →

Work at APETP? so we know who speaks for it.

Follow the file APETP engages with

One email on Tuesdays when a new position is filed on this file, from APETP or from anyone else on it. Only when there is something new.

We use your email for these updates, and PolicySpeak may contact you about the product. Unsubscribe in one click. Privacy policy.

Their record over time

APETP filed 2 positions between 26 Apr 2021 and 8 Nov 2023, across 1 of the 583 legislative files tracked here, attaching a full position paper 1 time.

2021 · 1 filed2023 · 1 filed

What they argued

Medicinal products for human usefiled 8 Nov 2023source

Our association seeks to protect the patient from the many fake therapies that can actively harm their health, delay or abandon scientifically endorsed treatment, or pay substantially for them. We believe that the measures proposed in the draft will bring about significant improvements in the research and technology of medicines, their efficacy and their safety, and thus the protection of patients.

Filed in Spanish · English published by the European Commission

Medicinal products for human usefiled 26 Apr 2021PDFsource

Good afternoon. I am Fernando Cervera Rodríguez, molecular biologist, representative and member of the Board of Directors of the Association for Protecting Pseudo-Scientific Therapias (www.apetp.com). Please find enclosed in this comment as coordinator of the First Worldwide manifesto against pseudosciences in health, the document setting out the request of 2750 scientists and health workers from 44 countries…

Filed in Spanish · English published by the European Commission

Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.

Put APETP next to another organization. Same files, same register facts, side by side. Compare →

Is this your organization?

Everything on this page comes from APETP’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.

Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.